BILASKA 10 mg, orodispersible tablet 10 tablets
Active ingredients: Bilastine
Commercialized according to BDPMDispensing in France: Prescription only
Orodispersible tablet10 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BILASKA 10 mg, comprimé orodispersible
- Pharmaceutical form
- comprimé orodispersible
- Route of administration
- orale
- Presentation description
- plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 10 comprimé(s)
- Marketing authorisation holder
- MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 12 Mar 2021
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68561919CIP73014044CIP133400930140444Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BILASTINEcomprimé | 10 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.